Free tool
FAERS Monitor: Microzide
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020504 or its brand name (Microzide, Hydrochlorothiazide). Reports on generic versions are filed under their own applications.
Reports
146,331
Serious
98,127
67% of reports
Hospitalization
50,335
Death reported
10,200
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue10,470
- nausea10,084
- drug ineffective9,765
- diarrhoea8,711
- pain7,943
- headache7,893
- dyspnoea7,876
- dizziness7,629
- arthralgia6,349
- off label use6,034
- asthenia5,795
- vomiting5,776
- fall5,775
- malaise5,387
- acute kidney injury5,152
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,310 |
| 2005 | 3,022 |
| 2006 | 3,005 |
| 2007 | 2,864 |
| 2008 | 3,115 |
| 2009 | 3,900 |
| 2010 | 5,287 |
| 2011 | 5,369 |
| 2012 | 5,907 |
| 2013 | 4,812 |
| 2014 | 6,176 |
| 2015 | 8,039 |
| 2016 | 8,663 |
| 2017 | 7,780 |
| 2018 | 10,001 |
| 2019 | 10,143 |
| 2020 | 9,294 |
| 2021 | 8,945 |
| 2022 | 8,828 |
| 2023 | 8,058 |
| 2024 | 7,549 |
| 2025 | 7,754 |
| 2026 | 5,505 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,907,828 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 5,152 | 5.0 | 4.8 | 15,913 |
| fallSignal | 5,775 | 2.5 | 2.5 | 5,287 |
| astheniaSignal | 5,795 | 2.2 | 2.2 | 3,960 |
| dizzinessSignal | 7,629 | 2.2 | 2.2 | 5,140 |
| arthralgiaSignal | 6,349 | 2.2 | 2.2 | 4,241 |
| dyspnoeaSignal | 7,876 | 2.0 | 2.0 | 4,073 |
| diarrhoea | 8,711 | 2.0 | 1.9 | 4,119 |
| fatigue | 10,470 | 1.9 | 1.9 | 4,929 |
| pain | 7,943 | 1.9 | 1.8 | 3,267 |
| nausea | 10,084 | 1.8 | 1.8 | 3,981 |
| headache | 7,893 | 1.8 | 1.8 | 2,966 |
| vomiting | 5,776 | 1.8 | 1.7 | 1,975 |
| malaise | 5,387 | 1.8 | 1.7 | 1,838 |
| drug ineffective | 9,765 | 1.1 | 1.0 | 42 |
| off label use | 6,034 | 1.0 | 1.0 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.